Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Comprehensive assessment of metabolic syndrome among rural Bangladeshi women

Authors: Subrina Jesmin, Md Reazul Islam, A M Shahidul Islam, Md Sohag Mia, Sayeeda Nusrat Sultana, Sohel Zaedi, Naoto Yamaguchi, Yoshio Iwashima, Michiaki Hiroe, Tetsu Watanabe

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Metabolic syndrome (MS), defined as a constellation of cardiovascular disease (CVD) risk factors, is one of the fastest growing public health burdens in the Asia-Pacific region. This trend is despite the fact that people in this region are no more overweight than Europeans and Americans. Unfortunately, in South Asia, MS screening has only been performed in a few countries other than Bangladesh. Therefore the present study is designed to conduct a comprehensive screening of MS in Bangladeshi rural women, which includes estimation of prevalence and assessment of risk factor.

Methods

A total of 1535 rural Bangladesh women aged ≥ 15 years were studied using a population based cross-sectional survey. The prevalence of MS was estimated using NCEP ATP III, modified NCEP ATP III and IDF criteria.

Results

The prevalence rates of MS were 25.60% (NCEP ATP III), 36.68% (modified NCEP ATP III), and 19.80% (IDF), as revealed by the present study. Furthermore, based on the NCEP ATP III criteria, 11.60% of the subjects were found to have excess waist circumference; 29.12% had elevated blood pressure, 30.42% had elevated fasting plasma glucose level, 85.47% had low HDL values and 26.91% had increased triglyceride values. Low plasma HDL level was found to be the most common abnormality in the target population and elevated waist circumference was the least frequent component.

Conclusions

The present study reveals a high prevalence of MS and its associated risk factors in rural Bangladeshi women. These findings are important in that they provide insights that will be helpful in formulating effective public health policy, notably the development of future health prevention strategies in Bangladesh.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the MS defined by the IDF and national cholesterol education program: the Norwegian HUNT 2 study. BMC Publ Health. 2007, 7: 220-10.1186/1471-2458-7-220.CrossRef Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the MS defined by the IDF and national cholesterol education program: the Norwegian HUNT 2 study. BMC Publ Health. 2007, 7: 220-10.1186/1471-2458-7-220.CrossRef
2.
go back to reference Magat C, Goel NK, Walia DK, Agawal N, Sharma MK, Kaur J, Singh R, Singh G: Metabolic syndrome: a challenging health issue in highly urbanized union territory of north India. Diabetol Metab Syndr. 2010, 2: 19-10.1186/1758-5996-2-19.CrossRef Magat C, Goel NK, Walia DK, Agawal N, Sharma MK, Kaur J, Singh R, Singh G: Metabolic syndrome: a challenging health issue in highly urbanized union territory of north India. Diabetol Metab Syndr. 2010, 2: 19-10.1186/1758-5996-2-19.CrossRef
3.
go back to reference Eapen D, Kalra GL, Merchant N, Arora A, Khan BV: Metabolic syndrome and cardiovascular disease in south Asians. Vasc Health Risk Manag. 2009, 5: 731-743.PubMedPubMedCentral Eapen D, Kalra GL, Merchant N, Arora A, Khan BV: Metabolic syndrome and cardiovascular disease in south Asians. Vasc Health Risk Manag. 2009, 5: 731-743.PubMedPubMedCentral
4.
go back to reference Gupta M, Singh N, Verma S: South Asians and cardiovascular risk: what clinicians should know. Circulation. 2006, 113: e924-e929. 10.1161/CIRCULATIONAHA.105.583815.CrossRefPubMed Gupta M, Singh N, Verma S: South Asians and cardiovascular risk: what clinicians should know. Circulation. 2006, 113: e924-e929. 10.1161/CIRCULATIONAHA.105.583815.CrossRefPubMed
5.
go back to reference Misra A, Misra R, Wijesuriya M, Banerjee D: The metabolic syndrome in South Asians: continuing escalation and possible solutions. Indian J Med Res. 2007, 125: 345-354.PubMed Misra A, Misra R, Wijesuriya M, Banerjee D: The metabolic syndrome in South Asians: continuing escalation and possible solutions. Indian J Med Res. 2007, 125: 345-354.PubMed
6.
go back to reference Mohan V, Deepa M: The metabolic syndrome in developing countries. Diabetes Voice. 2006, 51: 15-17. Mohan V, Deepa M: The metabolic syndrome in developing countries. Diabetes Voice. 2006, 51: 15-17.
7.
go back to reference Rahim MA, Hussain A, Khan AKA, Sayeed MA, Keramat Ali SM, Vaaler S: Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res Clin Pract. 2007, 77: 300-305. 10.1016/j.diabres.2006.11.010.CrossRefPubMed Rahim MA, Hussain A, Khan AKA, Sayeed MA, Keramat Ali SM, Vaaler S: Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res Clin Pract. 2007, 77: 300-305. 10.1016/j.diabres.2006.11.010.CrossRefPubMed
8.
go back to reference Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel: Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel: Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
10.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
11.
go back to reference Yen IH, Syme SL: The social environment and health: a discussion of the epidemiologic literature. Annu Rev Public Health. 1999, 20: 287-308. 10.1146/annurev.publhealth.20.1.287.CrossRefPubMed Yen IH, Syme SL: The social environment and health: a discussion of the epidemiologic literature. Annu Rev Public Health. 1999, 20: 287-308. 10.1146/annurev.publhealth.20.1.287.CrossRefPubMed
12.
go back to reference Argos M, Parvez F, Chen Y, Hussain AZ, Momotaj H, Howe GR, Graziano JH, Ahsan H: Socioeconomic status and risk for arsenic-related skin lesions in Bangladesh. Am J Public Health. 2007, 97: 825-831. 10.2105/AJPH.2005.078816.CrossRefPubMedPubMedCentral Argos M, Parvez F, Chen Y, Hussain AZ, Momotaj H, Howe GR, Graziano JH, Ahsan H: Socioeconomic status and risk for arsenic-related skin lesions in Bangladesh. Am J Public Health. 2007, 97: 825-831. 10.2105/AJPH.2005.078816.CrossRefPubMedPubMedCentral
13.
go back to reference Durkin MS, Islam S, Hasan ZM, Zaman SS: Measures of socioeconomic status for child health research: comparative results from Bangladesh and Pakistan. Soc Sci Med. 1994, 38: 1289-1297. 10.1016/0277-9536(94)90192-9.CrossRefPubMed Durkin MS, Islam S, Hasan ZM, Zaman SS: Measures of socioeconomic status for child health research: comparative results from Bangladesh and Pakistan. Soc Sci Med. 1994, 38: 1289-1297. 10.1016/0277-9536(94)90192-9.CrossRefPubMed
14.
go back to reference Das M, Pal S, Ghosh A: Rural urban differences of cardiovascular disease risk factors in adult Asian Indians. Am J Hum Biol. 2008, 20: 440-445. 10.1002/ajhb.20757.CrossRefPubMed Das M, Pal S, Ghosh A: Rural urban differences of cardiovascular disease risk factors in adult Asian Indians. Am J Hum Biol. 2008, 20: 440-445. 10.1002/ajhb.20757.CrossRefPubMed
15.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed
16.
go back to reference Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003, 26: 1781-1785. 10.2337/diacare.26.6.1781.CrossRefPubMed Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003, 26: 1781-1785. 10.2337/diacare.26.6.1781.CrossRefPubMed
17.
go back to reference Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003, 61: 29-37. 10.1016/S0168-8227(03)00066-4.CrossRefPubMed Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003, 61: 29-37. 10.1016/S0168-8227(03)00066-4.CrossRefPubMed
18.
go back to reference Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003, 163: 427-436. 10.1001/archinte.163.4.427.CrossRefPubMedPubMedCentral Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003, 163: 427-436. 10.1001/archinte.163.4.427.CrossRefPubMedPubMedCentral
19.
go back to reference Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D: Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care. 2003, 26: 3198-3199. 10.2337/diacare.26.11.3198.CrossRefPubMed Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D: Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care. 2003, 26: 3198-3199. 10.2337/diacare.26.11.3198.CrossRefPubMed
20.
go back to reference Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004, 27: 2444-2449. 10.2337/diacare.27.10.2444.CrossRefPubMed Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004, 27: 2444-2449. 10.2337/diacare.27.10.2444.CrossRefPubMed
21.
go back to reference Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K: Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004, 97: 257-261. 10.1016/j.ijcard.2003.11.003.CrossRefPubMed Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K: Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004, 97: 257-261. 10.1016/j.ijcard.2003.11.003.CrossRefPubMed
22.
go back to reference DECODE Study Group, Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women. Arch Intern Med. 2004, 164: 1066-1076. 10.1001/archinte.164.10.1066.CrossRef DECODE Study Group, Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women. Arch Intern Med. 2004, 164: 1066-1076. 10.1001/archinte.164.10.1066.CrossRef
23.
go back to reference Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, et al: Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care. 2004, 27: 2135-2140. 10.2337/diacare.27.9.2135.CrossRefPubMed Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, et al: Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care. 2004, 27: 2135-2140. 10.2337/diacare.27.9.2135.CrossRefPubMed
24.
go back to reference Jørgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K: Greenland Population Study Prevalence of the metabolic syndrome among the Inuit in Greenland: a comparison between two proposed definitions. Diabet Med. 2004, 21: 1237-1242. 10.1111/j.1464-5491.2004.01294.x.CrossRefPubMed Jørgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K: Greenland Population Study Prevalence of the metabolic syndrome among the Inuit in Greenland: a comparison between two proposed definitions. Diabet Med. 2004, 21: 1237-1242. 10.1111/j.1464-5491.2004.01294.x.CrossRefPubMed
25.
go back to reference Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, Gill T, Ruffin R: Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care. 2005, 28: 2777-2779. 10.2337/diacare.28.11.2777.CrossRefPubMed Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, Gill T, Ruffin R: Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care. 2005, 28: 2777-2779. 10.2337/diacare.28.11.2777.CrossRefPubMed
26.
go back to reference Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP: The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005, 21: 1157-1159. 10.1185/030079905X53333.CrossRefPubMed Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP: The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005, 21: 1157-1159. 10.1185/030079905X53333.CrossRefPubMed
27.
go back to reference Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M: NóvoaFJ: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med. 2005, 22: 1751-1756. 10.1111/j.1464-5491.2005.01745.x.CrossRefPubMed Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M: NóvoaFJ: Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med. 2005, 22: 1751-1756. 10.1111/j.1464-5491.2005.01745.x.CrossRefPubMed
28.
go back to reference Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care. 2005, 28: 2745-2749. 10.2337/diacare.28.11.2745.CrossRefPubMed Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care. 2005, 28: 2745-2749. 10.2337/diacare.28.11.2745.CrossRefPubMed
29.
go back to reference Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res. 2005, 28: 27-34. 10.1291/hypres.28.27.CrossRefPubMed Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res. 2005, 28: 27-34. 10.1291/hypres.28.27.CrossRefPubMed
30.
go back to reference Lorenzo C, Williams K, Gonzalez-Villalpando C, Haffner SM: The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care. 2005, 28: 2480-2485. 10.2337/diacare.28.10.2480.CrossRefPubMed Lorenzo C, Williams K, Gonzalez-Villalpando C, Haffner SM: The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care. 2005, 28: 2480-2485. 10.2337/diacare.28.10.2480.CrossRefPubMed
31.
go back to reference Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee, Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH: The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract. 2005, 67: 251-257. 10.1016/j.diabres.2004.07.022.CrossRef Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee, Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH: The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract. 2005, 67: 251-257. 10.1016/j.diabres.2004.07.022.CrossRef
32.
go back to reference He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB: Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol. 2006, 47: 1588-1594. 10.1016/j.jacc.2005.11.074.CrossRefPubMed He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, Li X, Hu FB: Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol. 2006, 47: 1588-1594. 10.1016/j.jacc.2005.11.074.CrossRefPubMed
33.
go back to reference Li ZY, Xu GB, Xia TA: Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis. 2006, 184: 188-192. 10.1016/j.atherosclerosis.2005.03.033.CrossRefPubMed Li ZY, Xu GB, Xia TA: Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis. 2006, 184: 188-192. 10.1016/j.atherosclerosis.2005.03.033.CrossRefPubMed
34.
go back to reference Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M: Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health. 2006, 6: 92-10.1186/1471-2458-6-92.CrossRefPubMedPubMedCentral Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M: Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health. 2006, 6: 92-10.1186/1471-2458-6-92.CrossRefPubMedPubMedCentral
35.
go back to reference Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007, 23: 127-134. 10.1002/dmrr.658.CrossRefPubMed Deepa M, Farooq S, Datta M, Deepa R, Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007, 23: 127-134. 10.1002/dmrr.658.CrossRefPubMed
36.
go back to reference Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N: High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord. 2001, 25: 1722-1729. 10.1038/sj.ijo.0801748.CrossRefPubMed Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N: High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord. 2001, 25: 1722-1729. 10.1038/sj.ijo.0801748.CrossRefPubMed
37.
go back to reference Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007, 370: 1829-1839.CrossRefPubMed Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007, 370: 1829-1839.CrossRefPubMed
38.
go back to reference Linsel-Nitschke P, Tall AR: HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov. 2005, 4: 193-205. 10.1038/nrd1658.CrossRefPubMed Linsel-Nitschke P, Tall AR: HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov. 2005, 4: 193-205. 10.1038/nrd1658.CrossRefPubMed
39.
go back to reference Von Eckardstein A: Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis. 2006, 186: 231-239. 10.1016/j.atherosclerosis.2005.10.033.CrossRefPubMed Von Eckardstein A: Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis. 2006, 186: 231-239. 10.1016/j.atherosclerosis.2005.10.033.CrossRefPubMed
40.
go back to reference Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F: Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol. 2009, 44: 136-160. 10.1016/j.exger.2008.11.003.CrossRefPubMed Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F: Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol. 2009, 44: 136-160. 10.1016/j.exger.2008.11.003.CrossRefPubMed
41.
go back to reference Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the middle east. The national survey of risk factors for non communicable disease of Iran. Diabetes Care. 2009, 32: 1092-1097. 10.2337/dc08-1800.CrossRefPubMedPubMedCentral Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the middle east. The national survey of risk factors for non communicable disease of Iran. Diabetes Care. 2009, 32: 1092-1097. 10.2337/dc08-1800.CrossRefPubMedPubMedCentral
42.
go back to reference Holleboom AG, Vergeer M, Hovingh GK, et al: The value of HDL genetics. Curr Opin Lipidol. 2008, 19: 385-394. 10.1097/MOL.0b013e328306a043.CrossRefPubMed Holleboom AG, Vergeer M, Hovingh GK, et al: The value of HDL genetics. Curr Opin Lipidol. 2008, 19: 385-394. 10.1097/MOL.0b013e328306a043.CrossRefPubMed
43.
go back to reference Zaman MM, Choudhury SR, Ahmed J, Numan SM, Islam MS, Yoshiike N: Non-biochemical risk factors for cardiovascular disease in general clinic-based rural population of Bangladesh. J Epidemiol. 2004, 14: 63-68. 10.2188/jea.14.63.CrossRefPubMed Zaman MM, Choudhury SR, Ahmed J, Numan SM, Islam MS, Yoshiike N: Non-biochemical risk factors for cardiovascular disease in general clinic-based rural population of Bangladesh. J Epidemiol. 2004, 14: 63-68. 10.2188/jea.14.63.CrossRefPubMed
44.
go back to reference Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, et al: Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract. 2010, 89: 181-188. 10.1016/j.diabres.2010.03.010.CrossRefPubMed Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, et al: Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract. 2010, 89: 181-188. 10.1016/j.diabres.2010.03.010.CrossRefPubMed
45.
go back to reference Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R: Intra-urban differences in the prevalence of the metabolic syndrome in southern India--the Chennai Urban Population Study (CUPS No. 4). Diabet Med. 2001, 18: 280-287. 10.1046/j.1464-5491.2001.00421.x.CrossRefPubMed Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R: Intra-urban differences in the prevalence of the metabolic syndrome in southern India--the Chennai Urban Population Study (CUPS No. 4). Diabet Med. 2001, 18: 280-287. 10.1046/j.1464-5491.2001.00421.x.CrossRefPubMed
46.
go back to reference Ramachandran A, Snehalatha C, Mohan V, Viswanathan M: Development of carbohydrate intolerance in offspring of Asian Indian conjugal type 2 diabetic parents. Diabetes Res Clin Pract. 1990, 8: 269-273. 10.1016/0168-8227(90)90126-E.CrossRefPubMed Ramachandran A, Snehalatha C, Mohan V, Viswanathan M: Development of carbohydrate intolerance in offspring of Asian Indian conjugal type 2 diabetic parents. Diabetes Res Clin Pract. 1990, 8: 269-273. 10.1016/0168-8227(90)90126-E.CrossRefPubMed
47.
go back to reference Srinivasan SR, Frontini MG, Berenson GS: Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes. Metabolism. 2003, 52: 443-450. 10.1053/meta.2003.50065.CrossRefPubMed Srinivasan SR, Frontini MG, Berenson GS: Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes. Metabolism. 2003, 52: 443-450. 10.1053/meta.2003.50065.CrossRefPubMed
48.
go back to reference Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V: Parental history of type 2 diabetes mellitus, metabolic syndrome and cardiometabolic risk factors in Asian Indian adolescents. Metabolism. 2009, 58: 344-350. 10.1016/j.metabol.2008.10.006.CrossRefPubMed Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V: Parental history of type 2 diabetes mellitus, metabolic syndrome and cardiometabolic risk factors in Asian Indian adolescents. Metabolism. 2009, 58: 344-350. 10.1016/j.metabol.2008.10.006.CrossRefPubMed
49.
go back to reference Rahim MA, Azad Khan AK, Sayeed MA, Akhtar B, Nahar Q, Ali SMK, Hussain A: Metabolic syndrome in rural Bangladesh: Comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements. Diabetes Metab Syndr Clin Res Rev. 2007, 1: 251-257. 10.1016/j.dsx.2007.09.006.CrossRef Rahim MA, Azad Khan AK, Sayeed MA, Akhtar B, Nahar Q, Ali SMK, Hussain A: Metabolic syndrome in rural Bangladesh: Comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements. Diabetes Metab Syndr Clin Res Rev. 2007, 1: 251-257. 10.1016/j.dsx.2007.09.006.CrossRef
50.
go back to reference Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93: S9-S30. 10.1210/jc.2008-1595.CrossRefPubMed Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93: S9-S30. 10.1210/jc.2008-1595.CrossRefPubMed
51.
go back to reference Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, et al: Heterogeneity of coronary heart risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. Br Med J. 1999, 319: 215-220. 10.1136/bmj.319.7204.215.CrossRef Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, et al: Heterogeneity of coronary heart risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. Br Med J. 1999, 319: 215-220. 10.1136/bmj.319.7204.215.CrossRef
52.
go back to reference Eriksson KF, Lindgärde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 1991, 34: 891-898. 10.1007/BF00400196.CrossRefPubMed Eriksson KF, Lindgärde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 1991, 34: 891-898. 10.1007/BF00400196.CrossRefPubMed
53.
go back to reference Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, et al: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997, 20: 537-544. 10.2337/diacare.20.4.537.CrossRefPubMed Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, et al: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997, 20: 537-544. 10.2337/diacare.20.4.537.CrossRefPubMed
54.
go back to reference Finnish Diabetes Prevention Study Group, Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350. 10.1056/NEJM200105033441801.CrossRef Finnish Diabetes Prevention Study Group, Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350. 10.1056/NEJM200105033441801.CrossRef
Metadata
Title
Comprehensive assessment of metabolic syndrome among rural Bangladeshi women
Authors
Subrina Jesmin
Md Reazul Islam
A M Shahidul Islam
Md Sohag Mia
Sayeeda Nusrat Sultana
Sohel Zaedi
Naoto Yamaguchi
Yoshio Iwashima
Michiaki Hiroe
Tetsu Watanabe
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-49

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue